Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
Botta GP, Abdelrahim M, Drengler RL, Aushev VN, Esmail A, Laliotis G, Brewer CM, George GV, Abbate SM, Chandana SR, Tejani MA, Malla M, Bansal D, Rivero-Hinojosa S, Spickard E, McCormick N, Cecchini M, Lacy J, Fei N, Kasi PM, Kasi A, Dayyani F, Hanna DL, Sharma S, Malhotra M, Aleshin A, Liu MC, Jurdi A.
Botta GP, et al.
Oncologist. 2024 Oct 3;29(10):859-869. doi: 10.1093/oncolo/oyae155.
Oncologist. 2024.
PMID: 39022993
Free PMC article.